Jane Ballantyne – författare

The Right to Pain Relief and Other Deep Roots of the Opioid Epidemic offers a new lens through which to view the opioid epidemic as a consequence of serious misunderstandings of both opioids and pain. Based on their extensive research and experience with chronic pain care, science, ethics, and policy, the authors look beyond the usual villains-pharmaceutical companies and pharmacotherapy distributors-to examine the ethical and scientific concepts about pain that made the opioid epidemic possible. The book explores the history of pain in Western society, the role of innovation in end-of-life care, the conception of pain control as an important medical responsibility, and the various models of pain that have led to our current understanding of it, ultimately arguing that we must reintegrate pain with the rest of human suffering as a necessary part of a full life. Containing patient vignettes as well as scientific and policy controversies that have emerged as the opioid epidemic has evolved, The Right to Pain Relief and Other Deep Roots of the Opioid Epidemic examines these implications in a more human and holistic way than has been ever addressed before by the popular press and professional literature.

Opioid treatment for chronic pain has been popularized over the past few decades, and opioid usage has increased several-fold. Opioid treatment of chronic pain increased for several reasons: a sense that chronic pain had previously been undertreated; strong underwriting of medical education by drug companies anxious to sell new "designer" opioids; lifting of the stigma associated opioids, particularly as pain advocacy reestablished opioids as necessary and appropriate treatment for acute and cancer pain. What has emerged is that there are several limitations to chronic opioid treatment. What has become clear in this unfortunate history is that non-specialists were persuaded to prescribe opioids before they could possibly understand the complexity of the treatment. So great were the pressures to prescribe, from drug companies, advocates, and many well-meaning people who saw opioids as the panacea for suffering, opioids were prescribed indiscriminately. It became almost impossible to deny opioids without seeming inhumane. What we learned though, is that while carefully selected and managed opioid therapy can benefit certain patients, casual use fails in several respects. What is needed then is a vast educational effort to help clinicians understand some of the complexities of opioid therapy, and in particular, how to select patients, and subsequently manage and monitor so as to achieve continued efficacy without losing control of pain and drug use. While no one educational effort can solve the whole problem, this book aims to provide clinicians with expert opinion on how to manage certain common scenarios involving opioid management of chronic pain. It will provide the reader not only with an easy reference to the management of common clinical scenarios where opioids are involved, but also with in depth analysis of the difficult issues surrounding a treatment that is both uniquely effective and potentially harmful.